Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 17 sep 2018 - 07:06
- Statutory name argenx SE
- Title argenx reports positive topline results from Phase 2 proof-of-concept trial of efgartigimod in primary immune thrombocytopenia
Date last update: 17 November 2018